[Changes in the spectrum of disease-causing bacteria].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001434:Bacteriophage Typing; D003141:Communicable Diseases / Q000382:microbiology*; D003428:Cross Infection / Q000382:microbiology; D004196:Disease Outbreaks; D005860:Germany, West; D006088:Gram-Negative Aerobic Bacteria / Q000472:pathogenicity; D006801:Humans; D007709:Klebsiella / Q000472:pathogenicity; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity; D013210:Staphylococcus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000188:drug therapy; D014733:Vibrio / Q000472:pathogenicity; D014734:Vibrio cholerae / Q000472:pathogenicity; D014946:Wound Infection / Q000382:microbiology
D000900:Anti-Bacterial Agents
Anderungen im Erregerspektrum.